Frequency of inducible clindamycin resistance among Gram-positive cocci in a tertiary hospital,Tehran, Iran
,
Abstract
Background and Objectives: Accurate designation of antimicrobial susceptibility pattern of the infecting microorganisms is an important crucial factor in making appropriate therapeutic decisions. Macrolide, lincosamide and streptogramin B antibiotics are in a family, reserved as an alternative approach in treatment of resistant Gram positive cocci. Amongst them, clindamycin has been considered as the preferred agent due to its excellent pharmacokinetic properties. The inducible resistance to clindamycin in Gram positive staphylococci and streptococci cannot be recognized by routine broth or agar based susceptibility tests and D-zone testing is necessary. This study is conducted to evaluate the frequency of inducible clindamycin resistance in Gram positive cocci.
Materials and Methods: Using traditional culture methods, 487 isolates of staphylococcus and β-hemolytic streptococcus were evaluated. If they were resistant to erythromycin and sensitive to clindamycin in primary antibiotic susceptibility testing by Kirby-Bauer method, they were subjected to D-zone testing to detect possible inducible clindamycin resistance.
Results: Thirty three out of 172 isolates of Staphylococcus aureus and 50 out of 277 isolates of coagulase-negative staphylococci (CoNS) were subjected for D-zone testing. Among them 13/33 and 28/50 showed inducible clindamycin resistance, respectively. There was no significant difference in inducible clindamycin resistance regarding to methicillin susceptibility pattern. Positive D-test was observed in 17.39 and 13.33% of Group B streptococci and Streptococcus spp., respectively.
Conclusion: Considerable number of isolates showed inducible clindamycin resistance in our study which falsely would be reported susceptible if D-zone testing was not performed. Thus, performing D-Zone testing is necessary to avoid misleading results which may cause treatment failure.
Mohansoundaram KM. The prevalence of inducible clindamycin resistance among gram positive coc- ci from various clinical specimens. J Clin Diagn Res2011; 5:38-40.
Kumar S, Umadevi S, Joseph N, Kali A, Easow J, Sri- rangaraj S, et al. Detection of inducible clindamycin resistance in Staphylococus aureus and coagulase-neg- ative staphylococci- a study from South India. Internet J Microbiol 2010; 9.
Sasirekha B, Usha MS, Amruta JA, Ankit S, Brinda N, Divya R. Incidence of constitutive and inducible clin- damycin resistance among hospital-associated Staphy- lococcus aureus. Biotech 2014; 4:85-89.
Lyall KDS, Gupta V, Chhina D. Inducible Clindamycin Resistance among clinical isolates of Staphylococcus aueus. J Mahatma Gandhi Inst Med Sci 2013; 18:112-115.
Prabhu K, Rao S, Rao V. Inducible clindamycin resis- tance in Staphylococcus aureus isolated from clinical samples. J Lab Physicians 2011; 3:25-27.
Lewis JS 2nd, Jorgensen JH. Inducible clindamycin re- sistancein Staphylococci: should clinicians and micro-biologists be concerned? Clin Infect Dis 2005; 40:280-285.
Renushri, Saha A, Nagaraj, Krihnamurthy V. Inducible clindamycin resistance in Staphylocccus aureus isolat- ed from nursing and pharmacy students. J Lab Physi- cians 2011; 3:89-92.
Jorgensen JH, Crawford SA, McElmeel ML, Fie- belkorn KR. Detection of inducible clindamcin resis- tance of staphylococci in conjuction with performance of automated broth susceptibility testing. J Clin Micro- biol 2004; 4:1800-1802.
Moore ZS, Jerris RC, Hilinski JA. High prevalence of inducible clindamycin resistance among Staphylococ- cus aureus isolates from patients with cystic fibrosis. J Cyst Fibros 2007;7:206-209.
Mahon CR, Lehman DC, Mauselis G, with 49 contrib- utors. (2011). Text book of diagnostic Microbiology,4th ed. Philadelphia Sunders/ Elsevier, US.
CLSI. Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. Wayne, PA: Clinical and Labo- ratory Standards Institute; 2011. 31:M100-S21.
Pal N, Sharma B, Sharma R, Vyas L. Detection of in- ducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India. J Postgrad Med 2010; 56:182-185.
Coyle EA, Lewis RL, Prince RA. Influence of clin- damycin on the release of Staphylococcus aureus al- pha-hemolysin from methicillin resistant S. aureus: Could MIC make a difference [abstract182]? Crit Care Med 2003; 31: A48.
Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003; 111:1265-1273.
Angel MR, Balaji V, Prakash J, Brahmadathan KN, Mathews MS. Prevalence of inducible clindamycin re- sistance in Gram positive organisms in a tertiary care center. Indian J Med Microbiol 2008; 26:262-264.
Fiebelkorn KR, Crawford SA, McElmeel ML, Jor- gensen JH. Practical disk diffusion method for detec- tion of inducible clindamycin resistance in Staphylo- coccus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41:4740-4744.
Schreckenerger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphy-lococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42:2777-2779.
Ajantha GS, Kulkarni RD, Shubhada C, Jain P. Phe- notypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates by using the lower limit of recommended inter-disk distance. Indian J Pathol Microbiol 2008; 51:376-378.
Eksi F, Gayyurhan ED, Bayram A, Karsligil T. Deter- mination of antimicroial susceptibility patterns and inducible clindamycin resistance in Staphylococcus aureus strains recovered from southeastern Turkey. J Microbiol Immunol Infect 2011; 44:57-62.
Ciraj AM, Vinod P, Sreejith G, Rajani K. Inducible clindamycin resistance among clinical isolates of staphylococci. Indian J pathol Microbiol 2009; 52:49-51.
Deotale V, Mendiratta DK, Raut U, Narang P. Inducible clindamycin resistance in Staphylcoccus aureus isolat- ed from clinical samples. Indian J Med Microbiol 2010;28:124-126.
Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Po- tential clindamycin resistance in clindamycin-suscep- tible, erythromycin-resistant Staphylococcus aureus: Report of a clinical failure. Antimicrob Agents Chemo- ther 2005; 49:1222-1224.
Patel M, Waites KB, Moser SA, Cloud GA, Hoesley CJ.Prevalence of inducible clindamycin resistance among community-and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol 2006; 44:2481-2484.
Dibah S, Arzanlou M, Jannati E, Shpouri R. Preva- lence and antimicrobial resistance pattern of methicil- lin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardail, Iran. Iran J Microbiol 2014; 6:163-168.
Pourmand MR, Hassanzadeh S, Mashhadi R, Askari E. Comparison of four diagnostic methods for detec- tion of methicillin resistant Staphylococcus aureus. Iran J Microbiol 2014; 6:341-344.
Ekrami A, Abbasi Montazeri E, Kaydani GA, Shokoo- hizadeh L. Methicillin resistant Staphylococci: Preva- lence and susceptibility patterns in a burn center in Ah- vaz from 2013-2014. Iran J Microbiol 2015; 7:208-213.
Hraoui M, Boutiba-Ben Boubaker I, Rachdi M, Slim A, Ben Redjeb S. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolates in Tunisia. J Med Microbiol 2012; 61:1109-1113.
| Files | ||
| Issue | Vol 8 No 4 (2016) | |
| Section | Articles | |
| Keywords | ||
| staphylococci streptococci inducible Clindamycin resistance D-test | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
